Returning to the pre-inflation shock level of over $57 means that WBA stock will have to gain more than 150% from here, and we don’t think this will materialize anytime soon. That said, WBA ...

WBA Stock Price Performance Walgreens shares have struggled in the past year, plummeting 62.9% compared with the industry’s 47.2% decline and the S&P 500’s 25.9% growth.

Walgreens Boots Alliance Inc. (NASDAQ: WBA) is a leading global retail pharmacy and healthcare company. The stock is trading down 60% from its 52-week high and with a stock performance down 58.5% ...

Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...

Walgreens Boots Alliance has significantly underperformed other retail stocks over the past year and analysts remain cautious about the stock’s prospects.

Despite these challenges, Walgreens saw its revenue grow from $120 billion in FY19 to $133 billion in FY22, partly due to contributions from COVID-19 vaccine and testing.

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement ...

Walgreens' stock price isn't going anywhere fast Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.

Operating loss was $325 million compared to $436 million in the prior-year period reflecting improved performance at VillageMD and Shields, Walgreens said in the first-quarter financial report.

Walgreens' stock price isn't going anywhere fast Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.

Walgreens Boots Alliance, the parent company of British retailer Boots, has seen its stock decline during a turbulent week after facing backlash over its allegedly "woke" Christmas advert.